28. Potassium sparing diuretics, ADH antagonists, osmotic diuretics Flashcards
Where do Potassium-Sparing Diuretics work?
Works on the tubules only
List the Vasopressin I and II agonists.
- Desmopressin: Vasopressin II agonist. Used in diabetes insipidus (no pressor effect).
- Ornipressin: Vasopressin I selective agonist. Acts as a pressor, given in combo with local anesthetics to inhibit systemic absorption.
List the primarily water-excreting diuretics.
- Osmotic diuretics
- ADH-antagonists
List some osmotic diuretics.
- Mannitol
- Glycerol
- Urea
- Isosorbide
What are the indications of osmotic diuretics?
- Cerebral edema (and other ↑ ICP cases): suck water from interstitial space. cause severe dehydration.
- Acute glaucoma attack or (ophthalmological surgery - to ↓ IOP prior to surgery)
- Acute renal failure: (only early, before anuria) absolutely CI if anuric patient, also CI in cerebral trauma…can worsen cerebral edema.
What are the side effects of using osmotic diuretics?
- Dehydration
- Pulmonary edema (acutely) – because mannitol rapidly draws water into the extracellular space, by extracting from cells–>edema.
- Hyponatremia: also from drawing water into EC space.Mannitol also has late hypernatremia due to excessive diuresis without water replacement.
- Exacerbation of HF due to ↑ EC space
List the V2R antagonists.
- Tolvaptan: V2 receptor antagonist. V2 is in kidney. Used for SIADH.
- Conivaptan: both vasopressin I and II receptor ATG. V1 is in vessels and causes vasoconstriction.
What are the indications of ADH-antagonists?
- Inappropriate ADH secretion conditions.
- Refractory edemas: (cirrhosis, nephrosis, HF) - but do not ↓ mortality long-term.
What is the mechanism of action of Aldosterone antagonists?
Aldosterone antagonists inhibit aldosterone receptors → ↓ expression of aldosterone-dependent Na/K-ATPase, Na transporters (ENaC), K+ channels on principal cells and H+-ATPase on α-intercalated cells
List the Aldosterone antagonist drugs.
- Spironolactone: non-selective. also acts on progesterone, glucocorticoid, and androgen receptors.
- Canrenone: spironolactone derivative.
- Eplerenone: spironolactone derivative. selective for aldosterone receptors.
What are the indications for Aldosterone antagonist use?
-
Hyperaldosteronism:
- Primary: Conn
- Secondary: due to refractory edemas via CHF, nephrotic syndrome, liver cirrhosis; any condition with ↓ intravascular volume
- Congestive heart failure: Eplerenone is only for CHF in Europe, in the US can also be used for HTN.(Heart Failure - can ↓ myocardial remodeling/fibrosis via ↓ aldosterone effects - ↑ volume, etc.)
- Hypertension: combo with K-wasting Diuretics - especially eplerenone. should not be combined with ACE-I (would cause hyperkalemia)
- (Polycystic Ovary Syndrome / Hirsutism - spironolactone blocks 17α-hydroxylase → ↓ testosterone levels)
What are the side effects of Aldosterone antagonists?
- Significant hyperkalemia. esp combo with ACE-I, ARB or BB
- Metabolic acidosis (non-anion gap, type 4 RTA: ): ↓ aldosterone effect → ↓ H-ATPase activity. (Sketchy: “Type 4 renal tubular acidosis” - only RTA type with hyperkalemia)
- Anti-androgenic action: antagonize testosterone. in men, long treatment → gynecomastia (due to androgen receptor inhibition) + other endocrine symptoms including: impotence, reduced libido, etc.
What are the indications for direct sodium transport blocker use?
- Hypertension
- Edema: usually in combo with thiazide
- Nephrogenic Diabetes Insipidus: specifically lithium-induced NDI; blocks Li entry into collecting duct cells → ↑ clearance of Li.
- Liddle syndrome (rare AD disorder of overactive ENaC)
NOTE: These drugs are not used so much, sometimes for hypertension. Overall they are not great drugs, hopefully won’t be around much longer.
Name the direct sodium transport blockers.
- Amiloride
- Triamterene
What is the MOA of direct sodium transport blockers?
They inhibit ENaC Sodium transporter in CT principal cells → ↓ Na reabsorption + ↓ K secretion.